Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
08 Sep 2017 ESMO 2017 Press Release: Patients with High Risk Prostate Cancer May Benefit “Equally” From Two New Treatments Genitourinary cancers
08 Sep 2017 ESMO 2017 Press Release: DNA Sequencing Could Open Up New Drug Indications for Patients with Rare Cancers Translational research
08 Sep 2017 ESMO 2017 Press Release: New Data Confirms Superiority of Docetaxel Based Triplet Therapy in Gastric Cancer Gastrointestinal cancers
08 Sep 2017 ESMO 2017 Press Release: LORELEI: Taselisib Boosts Breast Tumor Shrinkage Breast cancer
07 Sep 2017 ESMO 2017 Media Alert: Get ready for ESMO 2017: Nearly 23,000 Participants Set to Attend
07 Sep 2017 ESMO 2017 Media Alert: Challenges Faced by Adolescent and Young Adult Cancer Patients: Press Conference at the ESMO 2017 Congress
07 Sep 2017 ESMO 2017 Media Alert: Incoming Wave of Biosimilars in Oncology: Special Session at ESMO 2017
06 Sep 2017 ESMO 2017 Press Release: Some Stroke Survivors May Have Underlying Cancer Epidemiology/Etiology/Cancer Prevention
06 Sep 2017 Written Treatment Summaries Are Crucial to Meeting Needs for Information on Recurrence, Fertility, and Late Treatment Effects in Adolescent and Young Adult Cancer Survivors Cancer in Special Situations
06 Sep 2017 ESMO 2017 Press Release: Alectinib: ALEX and ALUR Trials Show CNS Benefit in NSCLC Lung and other thoracic tumours
05 Sep 2017 FDA Approves Gemtuzumab Ozogamicin for CD33-positive AML Haematologic malignancies - Anticancer agents & Biologic therapy
05 Sep 2017 ESMO 2017 Press Release: MIRO Trial: 3-year Outcomes Favour Laparoscopic Surgery for Oesophageal Cancer Gastrointestinal cancers
04 Sep 2017 Ribociclib Receives EU Approval as First-Line Treatment for HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
04 Sep 2017 ESMO 2017 Press Release: ICON8 Trial Reaffirms Standard Dosing in Ovarian Cancer Chemo Gynaecologic malignancies
03 Sep 2017 ESMO 2017 Press Release: Study in Early Stage Breast Cancer Shows That Even Small Tumours Can Be Aggressive Breast cancer